Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 6298.37 million | USD 20,939.21 million | 14.28% | 2023 |
The global cell culture media market size was worth around USD 6298.37 million in 2023 and is predicted to grow to around USD 20,939.21 million by 2032 with a compound annual growth rate (CAGR) of roughly 14.28% between 2024 and 2032. The report covers forecast and analysis for the cell culture media market on a global and regional level. This research study analyses the cell culture media market from 2024-2032 in detail, looking at its expected size, share, growth drivers, and forecasts.
The global cell culture media market is expected to grow significantly over the forecast period. Cell culture media are used for in vitro cultivation of cells. Culture media supports the growth of microorganisms such as bacteria or fungi which are further used for research and clinical studies for several applications. Increasing pharmaceutical and biotechnology industries, high return on investments, and advanced applications of in vitro cell culture are significantly propelling the growth of the cell culture media market.
The major factor driving the growth of cell culture media is the rising demand for treating chronic diseases in a customized way, which has increased the spending for cell culture development and is anticipated to drive the cell culture media market during the forecast period. Moreover, raising awareness about stem cell culture and its advanced applications in large-scale life science industries will also fuel the growth of the market during the forecast period. Moreover, the vast growth in biotechnology and pharmaceutical industrial activities worldwide and increasing spending in clinical research in developed as well as in developing economies is expected to drive the market during the forecast period.
However, to handle the cell culture process skilled personnel are required. Lack of skilled lab technicians and pharmacists in developing economies may limit the growth of the market. Unskilled lab technicians and pharmacists are unable to understand the proper protocol and system for in vitro cultivation which can affect the cell culture and its growth, resulting in the contamination of cell culture media, issues of reproducibility, the occurrence of heavy trace elements, and others thus posing as a challenge for the market.
The Global Pediatric Medicines industry is segmented based on by reagent type, by type, by applications, by end-user, and by region
By reagent type, the global cell culture media market is segmented into albumin, hormones, attachment factors, amino acid, and growth factors and cytokines
By Type, chemically-defined media, classical media, lysogeny broth, protein-free media, serum-free media, and specialty media
By applications, biopharmaceuticals and therapeutics segment accounted for the largest market share in 2023 and is expected to dominate the market by the end of forecast period. Increasing R&D activities and the introduction of new protocols and technologies for cell culture process will significantly propel the growth of the market. However, the biotech research application segment is expected to grow at highest CAGR during the forecast period, owing to increasing biotechnology companies in developing countries.
Based on end-users, the biotechnology and pharmaceutical companies contributed the majority of the market share. The factors such as increasing in vitro clinical research and ongoing technological developments in biotech and pharmaceutical industries such as commercialization of stem cells will boost the segment during the forecast period.
Report Attributes | Report Details |
---|---|
Report Name | Cell Culture Media Market Research Report |
Market Size in 2023 | USD 6298.37 Million |
Market Forecast in 2032 | USD 20,939.21 Million |
Growth Rate | CAGR of 14.28% |
Number of Pages | 214 |
Key Companies Covered | Analytical Biological Services Inc., Atlanta Biologicals Inc., BD Biosciences, Cell Essentials Inc., ClonTech Laboratories Inc., GE Healthcare, JR Scientific Inc., Life Technologies, Lonza Bioscience, Merck Millipore, MP Biomedicals, Novozymes Biopharma US Inc., Quality Biological Inc., SeraCare Life Sciences Inc., Siam Bioscience Co. Ltd., Sigma-Aldrich, Stemcell Technologies Inc., and Thermo Fisher Scientific Inc., among others. |
Segments Covered | By Reagent Type, By Type, By Applications, By End-User, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America contributes the largest share in the global cell culture media market. Increased government initiatives for research and clinical studies regarding chronic diseases such as cancer coupled with the presence of the well-developed biotechnology and pharmaceutical companies in the region will propel the growth of the market in North America during the forecast period. Europe holds the second largest share in global cell culture media market. High investments in research and biotech sectors, as well as the high adoption rate of new technologies, will lift the market in the European region. The Asia Pacific is anticipated to be the most lucrative region in the global cell culture media market owing to increasing biotechnology and pharmaceutical industries, technological developments in life science research, and rising initiatives for in vitro cultivations. Asia Pacific is expected to register the highest CAGR in the global cell culture media market. The increasing research base in China and India is expected to boost the growth of the market in the Asia Pacific.
By Reagent Type
By Type
By Application
By End-user
By Region
Report Brief
FrequentlyAsked Questions
Cell culture media play a pivotal role in the growth, maintenance, and proliferation of cells in vitro, serving as a critical component in various biomedical research, biopharmaceutical production, and regenerative medicine applications.
The global cell culture media market size was worth around USD 6298.37 million in 2023 and is predicted to grow to around USD 20,939.21 million by 2032.
The CAGR value of the cell culture media market is expected to be around of 14.28% during 2024-2032.
The key players operating in the market are Analytical Biological Services Inc., Atlanta Biologicals Inc., BD Biosciences, Cell Essentials Inc., ClonTech Laboratories Inc., GE Healthcare, JR Scientific Inc., Life Technologies, Lonza Bioscience, Merck Millipore, MP Biomedicals, Novozymes Biopharma US Inc., Quality Biological Inc., SeraCare Life Sciences Inc., Siam Bioscience Co. Ltd., Sigma-Aldrich, Stemcell Technologies Inc., and Thermo Fisher Scientific Inc., among others.
North America contributes the largest share in the global cell culture media market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed